3α-Androstanediol
A metabolite of dihydrotestosterone
3α-Androstanediol, also known as 5α-androstane-3α,17β-diol, is a steroid metabolite of dihydrotestosterone (DHT). It is an important compound in the androgen and estrogen metabolic pathways and plays a role in the neurosteroid system.
Chemical Structure and Properties[edit | edit source]
3α-Androstanediol is a C19 steroid with the chemical formula C19H32O2. It is characterized by the presence of hydroxyl groups at the 3α and 17β positions on the steroid backbone. This configuration distinguishes it from its isomer, 3β-androstanediol, which has a hydroxyl group at the 3β position.
Biosynthesis[edit | edit source]
3α-Androstanediol is synthesized from dihydrotestosterone (DHT) through the action of the enzyme 3α-hydroxysteroid dehydrogenase (3α-HSD). DHT is a potent androgen derived from testosterone via the enzyme 5α-reductase. The conversion of DHT to 3α-androstanediol reduces its androgenic activity, as 3α-androstanediol has a much lower affinity for the androgen receptor.
Physiological Role[edit | edit source]
3α-Androstanediol is considered a neurosteroid, meaning it is synthesized in the central nervous system and modulates neurotransmission. It has been shown to have effects on GABA_A receptors, enhancing GABAergic activity, which can influence mood, anxiety, and seizure susceptibility. This neurosteroid activity suggests a potential role in neurological and psychiatric conditions.
Clinical Significance[edit | edit source]
The levels of 3α-androstanediol can be indicative of certain medical conditions. For instance, altered levels may be observed in disorders of androgen metabolism or in conditions affecting the hypothalamic-pituitary-gonadal axis. It is also of interest in the study of androgen insensitivity syndrome and other endocrine disorders.
Research and Applications[edit | edit source]
Research into 3α-androstanediol is ongoing, particularly in the context of its role as a neurosteroid. Studies are exploring its potential therapeutic applications in anxiety disorders, depression, and epilepsy. Its interaction with the GABA_A receptor makes it a target for developing new pharmacological agents.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
